NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,440,218 | -52.1% | 140,099 | -15.1% | 0.00% | -66.7% |
| Q3 2022 | $3,004,000 | -57.8% | 165,046 | +19.2% | 0.00% | -57.1% |
| Q2 2022 | $7,120,000 | -36.8% | 138,435 | -9.5% | 0.01% | -22.2% |
| Q1 2022 | $11,268,000 | -52.4% | 152,998 | -7.5% | 0.01% | -43.8% |
| Q4 2021 | $23,663,000 | -30.9% | 165,393 | +0.1% | 0.02% | -38.5% |
| Q3 2021 | $34,264,000 | -0.4% | 165,281 | +2.0% | 0.03% | 0.0% |
| Q2 2021 | $34,400,000 | +28.6% | 162,026 | +9.8% | 0.03% | +30.0% |
| Q1 2021 | $26,760,000 | +76.4% | 147,595 | +8.5% | 0.02% | +66.7% |
| Q4 2020 | $15,174,000 | -0.4% | 136,081 | -3.2% | 0.01% | -14.3% |
| Q3 2020 | $15,237,000 | +40.7% | 140,624 | +8.2% | 0.01% | +27.3% |
| Q2 2020 | $10,833,000 | +3475.2% | 129,975 | +482.4% | 0.01% | – |
| Q1 2020 | $303,000 | +240.4% | 22,318 | 0.0% | 0.00% | – |
| Q4 2019 | $89,000 | -20.5% | 22,318 | 0.0% | 0.00% | – |
| Q3 2019 | $112,000 | -14.5% | 22,318 | 0.0% | 0.00% | – |
| Q2 2019 | $131,000 | – | 22,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |